ClinicalTrials.Veeva

Menu

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

HealthPartners Institute logo

HealthPartners Institute

Status and phase

Completed
Early Phase 1

Conditions

Sleep

Treatments

Drug: Zolpidem
Other: Lavender Aromatherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04102345
A19-156

Details and patient eligibility

About

In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.

Enrollment

58 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age >=18 years
  • In-center diagnostic or split night sleep study (PSG)

Exclusion criteria

  • No exclusion criteria

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

58 participants in 2 patient groups

Lavender
Experimental group
Description:
1-2 drops of Lavender (essential oil) in approximately 120 ml of distilled water is added to a diffuser 10 minutes before light out. The diffuser runs for approximately 2 hours before automatically being shut off. A low mist option is used on the diffuser.
Treatment:
Other: Lavender Aromatherapy
Zolpidem
Active Comparator group
Description:
Pre-prescribed, physician directed use of zolpidem. There is no dose exclusionary criteria for the zolpidem. This study does not have any dose specifications, anyone on zolpidem may be eligible.
Treatment:
Drug: Zolpidem

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems